Search - tctmd.com

Displaying 541 - 560 of 717

Sort: Relevancy | Date

News Daily News

La Protección Distal Incorpora un Estímulo Inicial a la Trombectomía en el Tratamiento de los cuadros de STEMI, aunque el Beneficio No es Duradero

L.A. McKeown

September 27, 2013

News Daily News

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Yael L. Maxwell

September 27, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

Yael L. Maxwell

August 05, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

News Daily News

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

L.A. McKeown

July 19, 2013

News Daily News

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

L.A. McKeown

July 19, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Jason Kahn

June 28, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Jason Kahn

April 26, 2013

Advertisement

La Protección Distal Incorpora un Estímulo Inicial a la Trombectomía en el Tratamiento de los cuadros de STEMI, aunque el Beneficio No es Duradero

El Recuento Basal de Glóbulos Blancos Predice el Tamaño del Infarto en los STEMI Anteriores

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Stroke After STEMI Unusual But Carries Poor Prognosis

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content